BlackRock’s Reviva Pharmaceuticals RVPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $21.9K | Sell |
57,553
-56,460
| -50% | -$21.5K | ﹤0.01% | 5060 |
|
|
2025
Q1 | $109K | Sell |
114,013
-1,086
| -0.9% | -$1.04K | ﹤0.01% | 4698 |
|
|
2024
Q4 | $208K | Buy |
115,099
+10,409
| +10% | +$18.8K | ﹤0.01% | 4556 |
|
|
2024
Q3 | $151K | Buy |
104,690
+1,758
| +2% | +$2.53K | ﹤0.01% | 4538 |
|
|
2024
Q2 | $132K | Buy |
102,932
+11,071
| +12% | +$14.2K | ﹤0.01% | 4582 |
|
|
2024
Q1 | $347K | Sell |
91,861
-377
| -0.4% | -$1.43K | ﹤0.01% | 4410 |
|
|
2023
Q4 | $475K | Buy |
92,238
+3,548
| +4% | +$18.3K | ﹤0.01% | 4362 |
|
|
2023
Q3 | $433K | Sell |
88,690
-1,316
| -1% | -$6.42K | ﹤0.01% | 4397 |
|
|
2023
Q2 | $527K | Buy |
90,006
+5,052
| +6% | +$29.6K | ﹤0.01% | 4381 |
|
|
2023
Q1 | $356K | Hold |
84,954
| – | – | ﹤0.01% | 4542 |
|
|
2022
Q4 | $361K | Buy |
84,954
+1,302
| +2% | +$5.53K | ﹤0.01% | 4611 |
|
|
2022
Q3 | $133K | Buy |
+83,652
| New | +$133K | ﹤0.01% | 5002 |
|
|
2022
Q2 | – | Sell |
-22,842
| Closed | -$56K | – | 5839 |
|
|
2022
Q1 | $56K | Sell |
22,842
-1,994
| -8% | -$4.89K | ﹤0.01% | 5313 |
|
|
2021
Q4 | $71K | Sell |
24,836
-8,634
| -26% | -$24.7K | ﹤0.01% | 5277 |
|
|
2021
Q3 | $136K | Buy |
33,470
+15,152
| +83% | +$61.6K | ﹤0.01% | 5004 |
|
|
2021
Q2 | $89K | Buy |
+18,318
| New | +$89K | ﹤0.01% | 5012 |
|